Actinium awards director 62.8K RSUs, 94.2K options
ATNM director C. David Nicholson received new restricted stock units and stock options as part of his equity compensation on September 2, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Actinium Pharmaceuticals, Inc. (ATNM) reported that director C. David Nicholson received equity awards on September 2, 2026. He was granted 62,800 shares of Common Stock in the form of restricted stock units that vest in three equal annual installments over three years. He also received a stock option for 94,200 shares of Common Stock at an exercise price of $1.00 per share, vesting in fifty equal monthly tranches and expiring on September 2, 2036. Following these awards, he holds 63,300 shares of Common Stock directly.
Insider Trade Summary
Grant/Award: 157,000 shares
Grant/Award
2 txns
Insider
Nicholson, C. David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 94,200 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 62,800 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 94,200 options (Direct);
Common Stock — 63,300 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 94,200 options (Direct);
Common Stock, 500 to 63,300 shares (Direct)
Footnotes (2)
- F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
- F2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
Key Figures
RSUs granted: 62,800 shares
Stock options granted: 94,200 shares
Stock option exercise price: $1.00 per share
+4 more
7 metrics
RSUs granted
62,800 shares
Restricted stock units of Common Stock granted on September 2, 2026
Stock options granted
94,200 shares
Stock option for Common Stock granted on September 2, 2026
Stock option exercise price
$1.00 per share
Exercise price for the 94,200-share stock option granted September 2, 2026
Option expiration date
September 2, 2036
Expiration of the 94,200-share stock option grant
Common Stock held after awards
63,300 shares
Direct non-derivative holdings following September 2, 2026 RSU grant
RSU vesting schedule
3 equal annual installments
1/3 each year over three years from the grant date
Option vesting tranches
50 monthly tranches
Options vest in fifty equal monthly installments beginning on grant date
Key Terms
restricted stock units, RSUs, stock options, exercise price, +1 more
5 terms
restricted stock units financial
"Represents a grant of restricted stock units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Represents a grant of restricted stock units ("RSUs")."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
stock options financial
"The stock options vest and become exercisable in fifty equal monthly tranches"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price": "1.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The RSUs vest as follows: 1/3 on the first anniversary of the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ATNM director C. David Nicholson receive on September 2, 2026?
He received 62,800 restricted stock units of Common Stock and a stock option for 94,200 shares of Common Stock with a $1.00 exercise price per share, both granted as equity compensation.
How do the new restricted stock units granted to ATNM director Nicholson vest?
The 62,800 RSUs vest in three equal installments: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary, and 1/3 on the third anniversary of the September 2, 2026 grant.
What are the vesting terms of Nicholson’s new ATNM stock options?
The 94,200 stock options vest and become exercisable in fifty equal monthly tranches beginning on the September 2, 2026 grant date, with an exercise price of $1.00 per share and an expiration date of September 2, 2036.
Were Nicholson’s September 2, 2026 ATNM transactions under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not checked, and no footnote indicates a trading plan, so the equity awards are reported without reference to a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
